CX3CL1 and hepatocellular carcinoma: With specific concern on HBV chronic infection, it was demonstrated that a differential expression of CX3CL1 produced by HBV-infected hepatocytes and hepatoma cells can affect the migration activity of CX3CR1+ immune cells, potentially contributing to the immunopathogenesis of HBV infection [22].